Trump to Sign Order Targeting Drug Prices in US

President Donald Trump is set to sign an executive order on May 12, 2025, at the White House that aims to significantly reduce prescription drug costs in the United States. The order will align Medicare drug pricing with the lowest global prices, aiming for a potential price reduction of up to 80%. This move is seen as a major shift in US healthcare economics and is expected to immediately impact consumer healthcare costs by potentially saving billions nationwide.